Veracyte, Inc. (VCYT)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 23.40 |
| Open | 23.44 |
| Bid | 22.84 x 200 |
| Ask | 22.91 x 400 |
| Day's range | 22.85 - 23.44 |
| 52-week range | 18.61 - 30.52 |
| Volume | |
| Avg. volume | 728,615 |
| Market cap | 1.749B |
| Beta (5Y monthly) | 1.65 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.93 |
| Earnings date | 06 Aug 2024 - 12 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 29.83 |
Business WireVeracyte to Participate in Upcoming Investor Conferences
SOUTH SAN FRANCISCO, Calif., May 15, 2024--Veracyte, Inc. (Nasdaq: VCYT) a leading cancer diagnostics company, today announced it will participate in the following investor conferences.
ZacksWall Street Analysts Believe Veracyte (VCYT) Could Rally 39.59%: Here's is How to Trade
The mean of analysts' price targets for Veracyte (VCYT) points to a 39.6% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Simply Wall St.Is Veracyte, Inc. (NASDAQ:VCYT) Trading At A 43% Discount?
Key Insights The projected fair value for Veracyte is US$35.05 based on 2 Stage Free Cash Flow to Equity Current share...
© 2024 Yahoo. All rights reserved.